429 related articles for article (PubMed ID: 16914565)
21. Malignant lymphoma in western Ethiopia.
Getachew A
East Afr Med J; 2001 Aug; 78(8):402-4. PubMed ID: 11921560
[TBL] [Abstract][Full Text] [Related]
22. Expression of cancer testis antigen CT45 in classical Hodgkin lymphoma and other B-cell lymphomas.
Chen YT; Chadburn A; Lee P; Hsu M; Ritter E; Chiu A; Gnjatic S; Pfreundschuh M; Knowles DM; Old LJ
Proc Natl Acad Sci U S A; 2010 Feb; 107(7):3093-8. PubMed ID: 20133697
[TBL] [Abstract][Full Text] [Related]
23. The expression of the Hodgkin's disease-associated antigen Ki-1 in cutaneous infiltrates.
van der Putte SC; Toonstra J; van Wichen DF; van Unnik JA; van Vloten WA
Acta Derm Venereol; 1988; 68(3):202-8. PubMed ID: 2455412
[TBL] [Abstract][Full Text] [Related]
24. Nodular lymphocyte predominant Hodgkin's lymphoma.
Siddiqui N; Al-Diab AI
Saudi Med J; 2005 Feb; 26(2):241-5. PubMed ID: 15770298
[TBL] [Abstract][Full Text] [Related]
25. Topoisomerase IIalpha expression as an independent prognostic factor in Hodgkin's lymphoma.
Doussis-Anagnostopoulou IA; Vassilakopoulos TP; Thymara I; Korkolopoulou P; Angelopoulou MK; Siakantaris MP; Kokoris SI; Dimitriadou EM; Kalpadakis C; Matzouranis M; Kaklamanis L; Panayiotidis P; Kyrtsonis MC; Androulaki A; Patsouris E; Kittas C; Pangalis GA
Clin Cancer Res; 2008 Mar; 14(6):1759-66. PubMed ID: 18347177
[TBL] [Abstract][Full Text] [Related]
26. Role and prognostic significance of the Ki-67 index in non-Hodgkin's lymphoma.
Broyde A; Boycov O; Strenov Y; Okon E; Shpilberg O; Bairey O
Am J Hematol; 2009 Jun; 84(6):338-43. PubMed ID: 19384938
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological correlations of TIMP-1 and TIMP-2 in Hodgkin's lymphoma.
Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T
Eur J Haematol; 2004 Jan; 72(1):1-9. PubMed ID: 14962256
[TBL] [Abstract][Full Text] [Related]
28. Biochemical and structural properties of a Hodgkin's disease-related membrane protein.
Nawrocki JF; Kirsten ES; Fisher RI
J Immunol; 1988 Jul; 141(2):672-80. PubMed ID: 3385212
[TBL] [Abstract][Full Text] [Related]
29. Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population.
Stein H; Gerdes J; Schwab U; Lemke H; Mason DY; Ziegler A; Schienle W; Diehl V
Int J Cancer; 1982 Oct; 30(4):445-59. PubMed ID: 6754630
[TBL] [Abstract][Full Text] [Related]
30. Aberrant FHIT protein expression in classical Hodgkin's lymphoma: a potential marker.
Zhao P; Lam AK; Lu YL; Zhong M; Chen LH; Pu XL
Pathology; 2006 Oct; 38(5):399-402. PubMed ID: 17008276
[TBL] [Abstract][Full Text] [Related]
31. Lymphomatoid papulosis, Ki-1+ lymphoma, and primary cutaneous Hodgkin's disease.
Kadin ME
Semin Dermatol; 1991 Sep; 10(3):164-71. PubMed ID: 1657104
[TBL] [Abstract][Full Text] [Related]
32. Frequency and prognostic relevance of cancer testis antigen 45 expression in multiple myeloma.
Andrade VC; Vettore AL; Regis Silva MR; Felix RS; Almeida MS; de Carvalho F; Zago MA; Caballero OL; Simpson AJ; Colleoni GW
Exp Hematol; 2009 Apr; 37(4):446-9. PubMed ID: 19211183
[TBL] [Abstract][Full Text] [Related]
33. The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.
Niens M; van den Berg A; Diepstra A; Nolte IM; van der Steege G; Gallagher A; Taylor GM; Jarrett RF; Poppema S; te Meerman GJ
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2280-4. PubMed ID: 17119058
[TBL] [Abstract][Full Text] [Related]
34. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
[TBL] [Abstract][Full Text] [Related]
35. Light-chain mRNA in lymphocyte-predominant and mixed-cellularity Hodgkin's disease.
von Wasielewski R; Wilkens L; Nolte M; Werner M; Georgii A
Mod Pathol; 1996 Mar; 9(3):334-8. PubMed ID: 8685237
[TBL] [Abstract][Full Text] [Related]
36. Malignant pleural effusion in Hodgkin's lymphoma. Report of a case with immunoperoxidase studies.
Peterson IM; Raible M
Acta Cytol; 1991; 35(3):300-5. PubMed ID: 1710403
[TBL] [Abstract][Full Text] [Related]
37. Identification of cancer/testis-antigen genes by massively parallel signature sequencing.
Chen YT; Scanlan MJ; Venditti CA; Chua R; Theiler G; Stevenson BJ; Iseli C; Gure AO; Vasicek T; Strausberg RL; Jongeneel CV; Old LJ; Simpson AJ
Proc Natl Acad Sci U S A; 2005 May; 102(22):7940-5. PubMed ID: 15905330
[TBL] [Abstract][Full Text] [Related]
38. [Proliferation of Reed-Sternberg cells in 5 Hodgkin's cell lines].
Tang Y; Schwarting R; Stein H
Zhonghua Yi Xue Za Zhi; 1991 Feb; 71(2):78-80, 8. PubMed ID: 1647840
[TBL] [Abstract][Full Text] [Related]
39. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
[TBL] [Abstract][Full Text] [Related]
40. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
